Eukles Asset Management cut its stake in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 4.9% during the 4th quarter, Holdings Channel.com reports. The firm owned 22,114 shares of the company’s stock after selling 1,132 shares during the quarter. Eukles Asset Management’s holdings in Colgate-Palmolive were worth $2,010,000 as of its most recent filing with the SEC.
Several other large investors have also made changes to their positions in CL. Union Bancaire Privee UBP SA purchased a new position in shares of Colgate-Palmolive in the fourth quarter valued at about $32,000. Hager Investment Management Services LLC bought a new stake in shares of Colgate-Palmolive in the fourth quarter worth about $36,000. Reston Wealth Management LLC bought a new stake in shares of Colgate-Palmolive in the third quarter worth about $42,000. Synergy Asset Management LLC bought a new stake in Colgate-Palmolive during the fourth quarter worth approximately $49,000. Finally, Capital Performance Advisors LLP bought a new stake in Colgate-Palmolive during the third quarter worth approximately $53,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several equities research analysts have weighed in on the company. Morgan Stanley reduced their price objective on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research note on Monday, February 3rd. Piper Sandler cut their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday, January 6th. Raymond James reaffirmed an “outperform” rating and set a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Royal Bank of Canada reiterated a “sector perform” rating and issued a $101.00 price target on shares of Colgate-Palmolive in a report on Wednesday, January 29th. Finally, Stifel Nicolaus dropped their target price on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $101.16.
Colgate-Palmolive Stock Up 1.3 %
Colgate-Palmolive stock opened at $86.81 on Monday. The stock has a market capitalization of $70.93 billion, a price-to-earnings ratio of 24.66, a PEG ratio of 4.12 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a current ratio of 0.41 and a quick ratio of 0.26. The business has a fifty day moving average price of $90.36 and a 200-day moving average price of $96.77. Colgate-Palmolive has a 1-year low of $82.68 and a 1-year high of $109.30.
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the business posted $0.87 earnings per share. Equities research analysts forecast that Colgate-Palmolive will post 3.73 EPS for the current fiscal year.
Colgate-Palmolive Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.30%. Colgate-Palmolive’s payout ratio is currently 56.82%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- 2 Defensive Energy Stocks to Hedge Against Trade Turmoil
- What Are Dividend Champions? How to Invest in the Champions
- 3 Mining Stocks Poised to Ride the Precious Metals Boom
- How to Most Effectively Use the MarketBeat Earnings Screener
- Cybersecurity Stocks Are Soaring—Here’s Why These 3 Stand Out
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.